A recent study indicates that patients who stop using popular weight-loss injections like Wegovy and Mounjaro tend to recover reduced body mass far faster than those who stop traditional diet and exercise plans.
Research printed in a leading medical journal points out that while obese individuals frequently drop substantial amounts of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month after stopping.
"People buying these medications should be cognizant of the risk of fast rebound weight gain when the medication is stopped," stated lead investigator Dr. Susan Jebb.
Such speed of regain means a reversion to starting mass in about one and a half years.
Analyzing Approaches
The study, which looked at 37 of studies involving thousands of participants, contrasted the results of GLP-1 agonists with conventional dieting.
Scientists emphasize that people who shed pounds through diet and exercise usually see a slower weight regain—perhaps 0.1 kg a month—post-intervention.
Understanding the Fast Rebound
Nutrition scientists propose the mechanism of the injections is key to understanding the heightened rebound.
These medications mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 levels several times higher than normal might result in the body to generate a reduced amount of its own natural hormone, and could diminish sensitivity to its effects," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this GLP-1 'fix' results in hunger is no longer kept in check, making overeating a significant risk."
A Chronic Issue?
Medical guidelines recommend the jabs for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Professionals contend that, given the significant potential of relapse, the treatment might need to be life-long.
This perspective is reinforced by drug manufacturers, who say that the results "highlight the long-term character of excess weight," akin to managing diseases like hypertension.
Patient Accounts
Individuals who have stopped the jabs explain a powerful resurgence of hunger.
"I experienced a trigger activating and you're instantly ravenous," described an individual.
The struggle is worsened if individuals have not adopted permanent lifestyle or habit changes during therapy.
Widespread Use
Figures suggest that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with desire continuing to grow.
- Adoption is higher among females compared to males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many access the drugs through private prescriptions rather than public health services.
Ultimately, clinicians emphasize that while the jabs are powerful agents for weight loss, they are not a magic cure and long-term success hinges on ongoing lifestyle support.
